We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$1.92B
AUM Growth
+$78M
Cap. Flow
-$35M
Cap. Flow %
-1.82%
Top 10 Hldgs %
37.71%
Holding
391
New
25
Increased
95
Reduced
143
Closed
25

Top Sells

Rank Stock Value
1
GTY
Getty Realty Corp
GTY
+$17.2M
2
PYPL icon
PayPal
PYPL
+$14.1M
3
GILD icon
Gilead Sciences
GILD
+$12.8M
4
PFE icon
Pfizer
PFE
+$6.96M
5
ORCL icon
Oracle
ORCL
+$6.89M

Sector Composition

Rank Sector Weight
1 Healthcare 20.39%
2 Energy 20.36%
3 Industrials 12.65%
4 Financials 8.88%
5 Consumer Staples 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWX icon
351
Avalon Holdings
AWX
$9.87M
$47K ﹤0.01%
23,602
QTRH
352
DELISTED
Quarterhill Inc. Common Shares
QTRH
$41K ﹤0.01%
30,833
+50
+0.2% +$69
WIN
353
DELISTED
Windstream Holdings Inc
WIN
$35K ﹤0.01%
+4,000
New +$53K
REFR icon
354
Research Frontiers
REFR
$17.9M
$29K ﹤0.01%
24,000
-200
-0.8% -$240
SGYP
355
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$29K ﹤0.01%
10,000
-2,952
-23% -$10.1K
SMIT
356
DELISTED
Schmitt Industries Inc
SMIT
$22K ﹤0.01%
12,000
CRNT icon
357
Ceragon Networks
CRNT
$193M
$21K ﹤0.01%
+10,000
New +$22.5K
ROX
358
DELISTED
Castle Brands, Inc.
ROX
$20K ﹤0.01%
15,000
SMTX
359
DELISTED
SMTC Corporation
SMTX
$13K ﹤0.01%
10,000
HEPA
360
DELISTED
Hepion Pharmaceuticals
HEPA
0
IMI
361
DELISTED
Intermolecular, Inc.
IMI
$10K ﹤0.01%
+10,000
New +$9.42K
SNMX
362
DELISTED
Senomyx, Inc.
SNMX
$7K ﹤0.01%
11,000
-66,300
-86% -$45.9K
NIHD
363
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$5K ﹤0.01%
10,000
-161,300
-94% -$95K
GCVRZ
364
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$5K ﹤0.01%
15,000
TRIP icon
365
CALL
TripAdvisor
TRIP
$1.68B
$4K ﹤0.01%
100
UTG.RT
366
DELISTED
Reaves Utility Income Fund
UTG.RT
$4K ﹤0.01%
+10,500
New +$2.13K
AG icon
367
First Majestic Silver
AG
$7.83B
-12,460
Closed -$104K
BF.B icon
368
Brown-Forman Class B
BF.B
$12.1B
-51,184
Closed -$1.59M
DAL icon
369
PUT
Delta Air Lines
DAL
$55.6B
-20,000
Closed -$1.07M
FRT icon
370
Federal Realty Investment Trust
FRT
$10.8B
-2,110
Closed -$267K
GILD icon
371
CALL
Gilead Sciences
GILD
$165B
-9,600
Closed -$679K
GILD icon
372
Gilead Sciences
GILD
$165B
-181,494
Closed -$12.8M
GTY
373
Getty Realty Corp
GTY
$2.18B
-683,955
Closed -$17.2M
KO icon
374
CALL
Coca-Cola
KO
$353B
-30,000
Closed -$1.35M
OXLC
375
Oxford Lane Capital
OXLC
$866M
-2,054
Closed -$102K

Similar funds

Ingalls & Snyder LLC's Q3 2017 Portfolio in Review

As of Q3 2017, Ingalls & Snyder LLC held 391 positions worth $1.92B, up 4.2% from $1.84B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Ingalls & Snyder LLC's Q3 2017 filing shows 25 new, 95 increased, 143 reduced and 25 closed positions. Its largest new stake was Tapestry: 227,488 shares worth $9.16M. The largest sale was Getty Realty Corp, an estimated $17.2M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Energy and Industrials.

  • Ingalls & Snyder LLC's largest Q3 2017 buy was Tapestry: 227,488 shares worth $9.16M.
  • Ingalls & Snyder LLC added most to DuPont de Nemours in Q3 2017, an estimated $5.19M increase.
  • Ingalls & Snyder LLC's biggest Q3 2017 reduction was PayPal, cutting an estimated $14.1M.
  • Ingalls & Snyder LLC fully exited Getty Realty Corp in Q3 2017, selling an estimated $17.2M.
  • Ingalls & Snyder LLC's ten largest holdings make up 38% of its $1.92B portfolio in Q3 2017.
  • Ingalls & Snyder LLC opened 25 new positions and closed 25 in Q3 2017.
  • Ingalls & Snyder LLC's portfolio value rose 4.2% quarter-over-quarter to $1.92B.

Based on Ingalls & Snyder LLC's 13F filing for Q3 2017, filed 20 Oct 2017.